Concourse Financial Group Securities’s Bionano Genomics BNGO Stock Holding History

Concourse Financial Group Securities’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22	Closed	-$241	–	246
2024 Q4	$241	Hold	22	–	–	﹤0.01%	2187
2024 Q3	$590	Hold	22	–	–	﹤0.01%	2124
2024 Q2	$881	Hold	22	–	–	﹤0.01%	2141
2024 Q1	$1.44K	Hold	22	–	–	﹤0.01%	2089
2023 Q4	$2.46K	Hold	22	–	–	﹤0.01%	1982
2023 Q3	$3.94K	Hold	22	–	–	﹤0.01%	1877
2023 Q2	$7.93K	Hold	22	–	–	﹤0.01%	1723
2023 Q1	$14.4K	Hold	22	–	–	﹤0.01%	1557
2022 Q4	$19K	Hold	22	–	–	﹤0.01%	1485
2022 Q3	$24K	Hold	22	–	–	﹤0.01%	1236
2022 Q2	$18K	Hold	22	–	–	﹤0.01%	1482
2022 Q1	$34K	Hold	22	–	–	﹤0.01%	1275
2021 Q4	$39K	Hold	22	–	–	﹤0.01%	1381
2021 Q3	$72K	Hold	22	–	–	﹤0.01%	1148
2021 Q2	$95K	Hold	22	–	–	0.01%	1009
2021 Q1	$105K	Sell	22 -2	-8%	-$11.3K	0.01%	909
2020 Q4	$45K	Sell	24 -12	-33%	-$4.48K	﹤0.01%	1186
2020 Q3	$14K	Buy	+36	New	+$14K	﹤0.01%	1460

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

CCM

Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Concourse Financial Group Securities's BNGO Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 22 shares — an estimated $241 sold.

Concourse Financial Group Securities first reported a position in BNGO in Q3 2020 and held it in 18 quarters. The position peaked at $105K in Q1 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

Concourse Financial Group Securities reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
Concourse Financial Group Securities sold 22 Bionano Genomics shares in Q1 2025, an estimated $241.
Concourse Financial Group Securities first reported a position in Bionano Genomics in Q3 2020 and held it in 18 quarters.
Concourse Financial Group Securities's Bionano Genomics position peaked at $105K in Q1 2021.
30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.